Point-of-Care Testing of Hemostasis in Cardiac Surgery.
An excessive perioperative blood loss, that requires transfusion of blood products, sometimes occurs in patients undergoing cardiopulmonary bypass for cardiac surgery. Blood loss and transfusion requirements in these patients may be reduced with a better control of heparin treatment and its reversal. Blood component administration in patients with excessive post-cardiopulmonary bypass bleeding has been empiric for a long time due to turnaround times of laboratory coagulation tests. Devices are now available for rapid, point-of-care assessment of hemostasis alterations to allow an appropriate, targeted therapy. In particular, a quick evaluation of platelet and coagulation defects with new point-of-care devices can optimize the administration of pharmacological and transfusion-based therapy in patients with excessive bleeding after cardiopulmonary bypass.
Prisco
Domenico
D
Dipartimento di Area Critica Medico Chirurgica - Sezione di Clinica Medica Generale e Cliniche Specialistiche, Università degli Studi di Firenze, Centro Trombosi, Azienda Ospedaliera Careggi, Firenze, Italy. priscod@ao-careggi.toscana.it
Paniccia
Rita
R